Mei Ri Jing Ji Xin Wen
Search documents
大阪发生持刀伤人事件 我领馆再次提醒近期避免前往日本
Mei Ri Jing Ji Xin Wen· 2026-02-15 04:13
日本紧急求助电话:110(警察)、119(急救、消防)、118(海上事故、海难) 外交部全球领事保护与服务应急热线(24小时):+86-10-12308或+86-10-65612308 中国驻大阪总领事馆领事保护与协助电话:06-6445-9427 2月15日,大阪市中央区道顿堀发生一起持刀伤人事件,造成1人死亡、2人受伤,其中1人失去意识。 近期日本部分地区治安环境不靖,类似恶性案件多发频发。值此春节假期之际,中国驻大阪总领事馆再 次提醒中国公民近期避免前往日本,再次提醒领区公民加强安全防范,密切关注当地治安形势,切实提 高安全防范意识,加强自我保护。 每经AI快讯,2月15日,中国驻大阪总领馆提醒领区中国公民加强安全防范。全文如下: ...
肿瘤药断供数月,患者“自费1万多元1瓶还买不到”
Mei Ri Jing Ji Xin Wen· 2026-02-15 04:12
近日,一则关于上海璎黎药业有限公司(以下简称"璎黎药业")"大门被封"的消息在业内不胫而走。这 家曾因研发出高选择性PI3Kδ抑制剂林普利塞片(商品名:因他瑞,以下简称"林普利塞")而声名鹊 起,并曾获得恒瑞医药2000万美元战略投资的明星Biotech(生物科技公司),如今却陷入窘境。 针对上述传闻,2月11日,璎黎药业发布声明称,公司所有经营活动均正常有序进行,各项研发、生 产、运营及服务工作均按计划稳步推进,并未出现任何影响公司正常运转的异常情形。 《每日经济新闻》记者(以下简称"每经记者")实探璎黎药业位于上海漕河泾康桥商务绿洲的注册地址 后发现,公司大门及各处出入口均贴有封条,部分办公室已处于清空状态,现场还有两名工人正在包装 设备仪器等。一名璎黎药业工作人员向记者表示,公司确实正在整体搬迁,主要原因是"和房东有一些 租房上的纠纷,并不是企业经营有什么大的问题"。 此外,也有多位患者向记者反映,林普利塞这款"救命药"自2025年四季度起就已出现断供的情况,在多 地医院和药店均已无法采购,此前药企承诺的赠药活动也成了一张"空头支票"。 2月10日上午,每经记者再次来到璎黎药业办公地点。经由货运电梯来到 ...
大模型三箭齐发、低调招聘,字节跳动不只想赢下AI“春节档”
Mei Ri Jing Ji Xin Wen· 2026-02-15 03:59
Core Insights - The domestic large model industry is experiencing a peak iteration ahead of the Spring Festival, with ByteDance launching its Doubao Model 2.0 series, which aims to enhance execution capabilities for complex real-world tasks [1][11] - The release of Doubao 2.0 marks the first major upgrade since its initial launch in May 2024, showcasing ByteDance's ambition in the AI sector [1][11] - Various AI products are rapidly being deployed in Spring Festival scenarios, with ByteDance investing significantly in AI chip production and recruitment to support its initiatives [1][11] Group 1: Product Launch and Features - Doubao 2.0 includes multiple models: Pro, Lite, and Mini, with the Pro version designed for complex reasoning and agent tasks, achieving top scores in various competitive assessments [7][8] - The model has improved instruction-following capabilities, maintaining consistency and control in executing multi-step tasks, which is crucial for its application as an agent [8][9] - Doubao 2.0 Pro has demonstrated superior performance in multi-modal understanding and real-time video analysis, enhancing its usability in dynamic environments [9][10] Group 2: Market Position and Competitive Landscape - ByteDance's rapid release of three core models highlights its strategic positioning in the competitive AI landscape, coinciding with other major releases from competitors like Alibaba and MiniMax [11][12] - The company aims to leverage the high traffic of the Spring Festival by integrating its AI technologies into major events, such as the Spring Festival Gala, enhancing user engagement through AI-generated content [14][15] - Industry experts emphasize that the ability to create product barriers will depend on financial strength, technological depth, and the capacity to meet user demands effectively [15]
肿瘤药断供数月,患者“自费1万多元1瓶还买不到”!知名药企大门被贴封条,部分办公室已清空,员工:整体搬迁,与房东有些纠纷
Mei Ri Jing Ji Xin Wen· 2026-02-15 03:46
Core Viewpoint - Shanghai Yingli Pharmaceutical Co., Ltd. is facing operational challenges, including relocation and supply issues with its key product, Linpulise, which has led to concerns among patients and stakeholders [1][12][14]. Group 1: Company Operations - Yingli Pharmaceutical has announced that all business activities are proceeding normally, with research, production, and operations on schedule despite rumors of operational disruptions [2][12]. - The company is currently undergoing relocation due to disputes with its landlord, not due to significant operational issues [2][9]. - As of the latest reports, the company has around 30 employees remaining at its current location, with some staff involved in packing and moving equipment [3][8]. Group 2: Product Supply Issues - Linpulise, a critical drug for patients, has been in short supply since the fourth quarter of 2025, with reports of unfulfilled patient assistance programs [14][15]. - Patients have expressed difficulties in obtaining Linpulise, which has led to a search for alternative treatments [15][16]. - The drug was previously included in the national medical insurance directory but was removed in the latest update, limiting its market access and increasing its retail price to 11,040 yuan per bottle [17][18]. Group 3: Legal and Financial Challenges - Yingli Pharmaceutical has been involved in over 30 lawsuits since 2025, primarily related to contract disputes with suppliers and service providers [18]. - The company has been ordered to pay approximately 2.25 million yuan due to a legal ruling related to a service contract dispute [18]. - The financial strain from these legal issues and operational challenges has raised concerns about the company's future viability and its ability to meet obligations to suppliers and patients [18]. Group 4: Future Prospects - The future of Yingli Pharmaceutical may hinge on its partnership with Heng Rui Medicine, which has invested in the company and holds commercialization rights for Linpulise [18]. - Heng Rui Medicine has stated that it is actively assisting with related matters and that discussions regarding future cooperation are ongoing [18].
楼市回暖!上海二手房交易中心“乌泱泱挤满人”,单日成交可达上千套!中介:近期房东反而不着急了,买房人着急
Mei Ri Jing Ji Xin Wen· 2026-02-15 03:46
交易过户现场,买卖双方签署文件 图片来源:每经记者 包晶晶 摄 每经记者|包晶晶 每经编辑|段炼 董兴生 向江林 交易双方签字、确认,完成年前最后一单交易过户,忙碌了一年的李小忆就准备放假了。但2月11日这天对他来说又稍有些不同,送走客户后,他再次取 号,径直走向30号窗口,领到了自己的不动产证。 "以往每次来,都是帮客户领房产证,今天我领到了自己的房产证,还是蛮开心的!" 李小忆是21世纪不动产上海杨浦区一家门店的店长,盘点过去一年,李小忆感慨说,成交的大多是老公房,房价距离最高点几乎打了"骨折",中介收入自 然也相应打折。 不过,最近连续三个月的数据和市场表现,让他对接下来的"金三银四"充满了希望。据上海中原地产数据,2026年1月,上海二手住宅成交2.03万套,环 比微跌0.38%,同比增加26.69%,二手房走出了暖冬行情。 从业者:"房价变化要辩证地看" 作为房产中介行业的"老兵",李小忆也在2022年买入一套大户型新房,尽管近年来房地产深度调整,但他们一家早已搬入新居,开启了全新生活,房价在 自住需求面前,很少被提起。 谈及这两年的市场变化,李小忆举了个例子,自己的一位客户在2018年买了第一套住 ...
高毅资产去年四季度加仓 拼多多、贝壳等
Mei Ri Jing Ji Xin Wen· 2026-02-15 03:37
Core Insights - Gao Yi Asset disclosed its US stock holdings as of the end of 2025, indicating a total market value exceeding 600 million USD across 13 companies [2] - The firm increased its positions in Chinese concept stocks such as Pinduoduo and Beike in the fourth quarter of the previous year, and initiated a new investment in Yixian E-commerce [2] - The top ten holdings of Gao Yi Asset in the US stock market include Huazhu Group, Pinduoduo, Google, Yum China, Beike, Wuxi AppTec, NetEase, iQIYI, TSMC, and ISHARES TR, with Chinese concept stocks dominating the portfolio [2]
反向过年新潮流:老外扎堆来中国 单日飞三亚外国游客大增3倍
Mei Ri Jing Ji Xin Wen· 2026-02-15 03:25
(文章来源:每日经济新闻) 从入境游增幅来看,三亚表现尤为抢眼,使用非中国护照飞赴三亚的同比增幅超过3倍,显示出免税购 物和热带度假的强大吸引力。 从客源地看,来中国过年的外国游客中,澳大利亚、越南、新加坡、俄罗斯、英国、阿联酋、印尼、美 国等国家排名靠前。其中,一些远道而来的外国游客,增长尤为明显,澳大利亚和西班牙游客同比增长 均超3倍,法国、意大利等欧洲国家游客预订量也实现2倍以上增长。 2月15日,去哪儿旅行发布《2026春节假期首日出行报告》,数据显示,当日使用非中国护照预订国内 航班的数量同比增长近两成。外国游客热门目的地仍以一线城市为主,上海、北京、成都位列前三,但 一批宝藏小城也迎来"洋面孔",如济宁、鄂尔多斯、琼海、北海、阿勒泰等。 ...
桥水去年Q4增持英伟达和黄金股, 减持谷歌、微软
Mei Ri Jing Ji Xin Wen· 2026-02-15 02:16
Group 1 - Bridgewater, the world's largest hedge fund, disclosed its U.S. stock holdings report (13F) as of the end of 2025 [2] - In Q4 2025, Bridgewater increased its positions in technology stocks such as Micron Technology, Oracle, NVIDIA, and Amazon, as well as in gold stocks like Newman Mining [2] - The fund reduced its holdings in stocks like Google and Microsoft [2]
中科电气:公司正通过一体化项目建设改变公司石墨化自给率相对较低的局面 速看
Mei Ri Jing Ji Xin Wen· 2026-02-15 02:08
Core Viewpoint - The company is working on integrated project construction to improve its relatively low self-sufficiency rate in graphitization, driven by increasing demand in the downstream electric vehicle and energy storage markets [1] Group 1: Company Developments - The company reported that the shipment volume of lithium-ion battery anode materials is expected to continue its growth trend by Q4 2025, supported by rising demand in fast-charging electric vehicles and energy storage [1] - Due to insufficient in-house graphitization capacity, the company has increased outsourcing, which has led to certain cost pressures [1] - The company is implementing measures such as increasing R&D investment, enhancing product innovation, and launching differentiated products to improve cost control and market competitiveness [1] Group 2: Industry Context - The anode materials industry is currently facing a structural and phase imbalance in supply and demand, which has not fundamentally changed, leading to intense market competition and some compression of profit margins [1]